Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
X
Scientific presentation

Clonal evolution underlying clinical responses and relapses in subjects with IDH1-mutated AML treated with ivosidenib monotherapy or ivosidenib + azacitidine


Dylan Marchione, PhD
Description

At this year’s World CB & CDx conference held in Boston, Dylan Marchione, PhD, of Servier Pharmaceuticals presented data supporting the use of the Tapestri Platform in clinical development to elucidate clonal evolution patterns in patients with IDH1-mutated AML treated with combination therapy, TIBSOVO + azacitidine, as compared to monotherapy.



VIEW


Scientific presentation
From Cells to Cures: Panel Discussion on Advancing Clonal Profiling in Leukemia & Myeloma With Single-Cell Multiomics
Hervé Avet-Loiseau, MD, PhD
Felipe Prósper, MD, PhD
Cedric Dos Santos, PhD
Todd Druley, MD, PhD
(2023)
Scientific presentation
Single Cell Multi-Omics & the MRD Horizon
Todd Druley, MD, PhD
Blake Alexander
(2023)
Scientific presentation
Myeloma Matters: Advancing Research and Therapy Development with Single-cell DNA + Protein Multi-Omics
Todd Druley, MD, PhD
Adam Sciambi, PhD
(2023)
Scientific presentation
scTAM-seq: A Novel Method for Profiling DNA Methylation in Single Cells
Michael Scherer, PhD
Agostina Bianchi
(2023)
REQUEST QUOTE